Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.
Department of Public Health Services, Medical University of South Carolina, Charleston, South Carolina, USA.
Cancer. 2023 Apr 15;129(8):1237-1252. doi: 10.1002/cncr.34680. Epub 2023 Feb 9.
The current study examined self-reported human papillomavirus (HPV) vaccination uptake and intentions, and associations with psychosocial constructs among United States adults aged 18 to 26 and 27 to 45 years.
Data were collected via an online survey from participants recruited from a research panel. Outcomes were HPV vaccination uptake and intentions. Multivariable binary and ordered logistic regression models were used to examine associations between HPV vaccination outcomes and psychosocial constructs, sociodemographics, and previous health behaviors.
HPV vaccination uptake in both age cohorts (N = 2722) was associated with multiple variables, including but not limited to: provider recommendation (adjusted odds ratio [aOR], 11.63 [95% CI, 7.70-17.56] and aOR, 14.26 [95% CI, 9.52-21.38], for those aged 18 to 26 and 27 to 45 years, respectively) and positive HPV vaccine attitudes (aOR, 2.40 [95% CI, 1.70-3.40] and aOR, 1.46 [95% CI,1.06-2.02]). Among those who did not report or were unsure of prior HPV vaccination (N =1894), only 4.6% and 8.1% (aged 18-26 and 27-45 years, respectively) reported being very likely to receive the HPV vaccine in the next year. Increased intentions were associated with more positive vaccine attitudes (aOR, 2.45 [95% CI, 1.91-3.15] and aOR, 2.19 [95% CI, 1.72-2.78]) and provider recommendation (yes vs no; aOR, 1.97 [95% CI, 1.38-2.83] and aOR, 1.82 [95% CI, 1.31-2.52]; don't know/can't remember vs no; aOR, 1.38 [95% CI, 1.03-1.84] and aOR, 1.60 [95% CI, 1.17-2.18]). Sociodemographics and health behaviors associated with increased intentions differed for each age cohort.
Individual and interpersonal factors were associated with HPV vaccination uptake and intentions. Findings reveal the need for targeted interventions to improve HPV vaccination rates among these age groups.
本研究调查了美国 18 至 26 岁和 27 至 45 岁成年人的 HPV 疫苗接种率和接种意愿,以及与 HPV 疫苗接种相关的心理社会因素。
通过在线问卷调查收集参与者数据,这些参与者是从研究小组中招募的。研究结果是 HPV 疫苗接种率和接种意愿。采用多变量二项和有序逻辑回归模型来研究 HPV 疫苗接种结果与心理社会因素、社会人口统计学和既往健康行为之间的关系。
两个年龄组(共 2722 人)的 HPV 疫苗接种率均与多个变量相关,包括但不限于:医生推荐(调整后的优势比[aOR],18-26 岁年龄组为 11.63 [95%置信区间[CI],7.70-17.56]和 aOR,27-45 岁年龄组为 14.26 [95% CI,9.52-21.38])和 HPV 疫苗态度积极(aOR,2.40 [95% CI,1.70-3.40]和 aOR,1.46 [95% CI,1.06-2.02])。在那些没有报告或不确定是否接种过 HPV 疫苗的人(n=1894)中,只有 4.6%和 8.1%(18-26 岁和 27-45 岁年龄组)表示他们在未来一年内很可能会接种 HPV 疫苗。较高的接种意愿与更积极的疫苗态度相关(aOR,2.45 [95% CI,1.91-3.15]和 aOR,2.19 [95% CI,1.72-2.78])和医生推荐(是与否;aOR,1.97 [95% CI,1.38-2.83]和 aOR,1.82 [95% CI,1.31-2.52];不知道/不记得与否;aOR,1.38 [95% CI,1.03-1.84]和 aOR,1.60 [95% CI,1.17-2.18])。与接种意愿增加相关的社会人口统计学和健康行为因年龄组而异。
个体和人际因素与 HPV 疫苗接种率和接种意愿相关。研究结果表明,需要针对这些年龄组进行有针对性的干预,以提高 HPV 疫苗接种率。